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Abstract 
 
Purpose: Proton radiation therapy (PRT) is a standard treatment of uveal 
melanoma. PRT patients undergo implantation of ocular tantalum markers (OTMs) 
for treatment planning. Ultrahigh field MRI is a promising technique for 3D tumor 
visualization and PRT planning. This work examines MR safety and compatibility of 
OTMs at 7.0 Tesla. 
Methods: MR safety assessment included deflection angle measurements (DAM), 
electromagnetic field (EMF) simulations for SAR estimation and temperature 
simulations for examining RF heating using a bow tie antenna for transmission. MR 
compatibility was assessed via susceptibility artifacts in agarose, ex-vivo pig eyes 
and in an ex-vivo tumor eye employing gradient echo and fast spin-echo imaging.  
Results: DAM (<1°) demonstrated no risk due to magnetically-induced OTM 
deflection. EMF simulations showed that an OTM can be approximated by a disk, 
demonstrated the need for averaging masses of mave=0.01g to accommodate the 
OTM, and provided SAR0.01g,maximum=2.64 W/kg (Pin=1W) in OTM presence.A transfer 
function was derived, enabling  SAR0.01g-estimation for individual patient scenarios 
without the OTM being integrated. Thermal simulations revealed minor OTM related 
temperature increase (T<15 mK). Susceptibility artifact size (<8 mm) and location 
suggest no restrictions for MRI of the nervus opticus. . 
Conclusion: OTMs are not a per-se contraindication for MRI. 
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Introduction 
Proton radiation therapy (PRT) is one of the standard therapeutic approaches 
applied to patients suffering from uveal melanoma, the most prevalent primary 
intraocular malignancy world-wide with an incidence of 1/100,000 new cases per 
year (1-6). PRT of ocular tumors has been performed in >28,000 patients (7-9). 
Most of the ocular tumor patients scheduled for PRT undergo an implantation of 
ocular tantalum markers (OTM) which are sutured to the sclera (10, 11) and used in 
tumor localization, treatment planning and patient positioning prior to irradiation 
(11-14). 
Progress in magnetic resonance imaging (MRI) has permitted advances in the 
diagnosis of malignant melanomas of the uveal tract and planning of PRT. The 
spatial resolution and tissue contrast benefits of MRI versus A- and B-scan 
ultrasound measurements and low tissue contrast computed tomography permit a 
clearer delineation of the tumor margins (15). However, the delineation of an 
extrascleral extension and the assessment of tumor invasion into the optic nerve or 
the vortex veins continues to pose a challenge for radiation planning and 
radiotherapy directed at ocular tumors (3, 16). This challenge is due to spatial 
resolution constraints of MRI at 1.5 T and 3.0 T. Given the gain in spatial resolution 
in ultrahigh field (UHF) MRI (B0≥7.0 T) it is conceptually appealing for in vivo 
imaging, 3D visualization and PRT planning in cases of uveal melanoma (17-24). 
A broad spectrum of conducting implants have been declared MR safe (25), 
but to the best of our knowledge no data has been published on the MR safety and 
MR compatibility of OTMs. A detailed analysis of MR safety and MR compatibility of 
OTMs will play a key role in whether the potentially powerful combination of UHF-MR 
guided PRT advances or is dismissed. 
Realizing the safety requirements and the clinical opportunities of ophthalmic 
MRI, this work examines the MR safety and MR compatibility of OTMs. Recognizing 
the underserved clinical needs we hypothesize that MRI in the presence of OTMs 
would cause radiofrequency (RF) induced temperature increase and displacement 
that does not exceed regulatory limits and RF exposure guidelines (26, 27) at 7.0 T. 
To test this hypothesis, we examined radiofrequency heating, magnetically induced 
displacement and artifact formation caused by magnetic susceptibility.  
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Methods 
Ocular tantalum marker 
OTMs are button-like implants sutured to the sclera of the diseased eye close 
to the tumor (Fig.1a,b). Placement on the dorsal half of the eye is often chosen to 
increase patient comfort while blinking and to avoid radiation loss in the umbra of 
the metallic implant. OTM implantation commonly involves four markers, three of 
which are placed close to the borders of the tumor mass (Fig.1b). The position of 
the fourth marker is usually diametrically opposed so that small eye movements can 
be monitored (Fig.1b). Implant parameters are: Altomed Limited (Boldon, Tyne and 
Wear, England), diameter D=2.5 mm, thickness=0.17 mm, two holes with 
D=0.85 mm, weight=mimplant=17.1 mg (Fig.1a). The OTMs investigated in this study 
were obtained from the only manufacturer providing CE certification for the use of 
the markers in proton beam therapy of ocular tumors. 
Magnetically induced displacement  
The displacement force induced by the magnetic field gradient was evaluated 
using the deflection method (28). An OTM was hung on an in-house built holder, 
equipped with a hook to hold the implant at the center of an angular gauge (radius 
of curvature 25 cm). A polyester USP 9-0 suture (Ethicon INC, Johnson&Johnson 
Medical GmbH, Norderstedt, Germany, D=30 µm, msuture=30 ng, mthread<1% of 
mOTM) was used (28). The setup was placed at the front end of a 7.0 T human MR 
system (Magnetom, Siemens Healthcare, Erlangen, Germany) where the B0 gradient 
is strongest (dB/dz≈5 T/m).  
Radiofrequency induced heating 
Radiofrequency-induced heating was evaluated by assessing specific 
absorption rate (SAR) and temperature in the tissue simulating material (TSM) in 
the presence of an OTM using IEC limits for safe operation as a reference (26, 27). 
Electromagnetic field (EMF) simulations were conducted with the finite 
difference time domain method (Sim4Life V2.0, ZMT, Zurich, Switzerland). The 
virtual implant was placed in a rectangular phantom model (Fig.1c) filled with TSM 
resembling the conductivity of the sclera (σ=0.94 S/m, ε=79, ρ=1.041 g/cm³) (29). 
A meshbox (isotropic resolution=0.05 mm, size=(10x10x10) mm³) was defined 
around the OTM. This high resolution mesh box was encased by a region (isotropic 
resolution=0.1 mm, size=(15x15x32.5) mm³) to save CPU time. This setup was 
placed underneath the center of a virtual bowtie electric dipole RF antenna 
(l=15 cm, (30)) used for RF transmission (Pin, peak=1 W) (Fig.1c). This approach 
yields well defined E-field vectors in relation to the positioning of the implant (31).  
If an electrically conductive passive implant such as an OTM is subjected to 
an incident electric field, surface currents and charges must be induced to 
superimpose a scattered E-field on the incident E-field to meet the boundary 
condition ?⃗? tan|total = ?⃗?
 
tan|inc + ?⃗?
 
tan|sca = 0 (32). The superposition of ?⃗?
 
incand ?⃗? sca might 
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lead to a local increase in absolute E-fields |?⃗? |, which increase 𝑆𝐴𝑅 ∝ |?⃗? |
2
 (32). E-field 
coupling was investigated for the button like geometry of the implant, which was 
modeled as a perfect electric conductor (PEC). We investigated the influence of the 
orientation ϑ of the holes with respect to the electric field lines on the surface 
current induced on the implant as well as on the RF power deposition for ϑ1=0°, 
ϑ2=45° and ϑ3=90°. As a mean of generalization for differing implant orientation, 
we studied the E-field coupling to a disk (PEC) with the same outer dimensions as 
the implant. To resemble the positioning of the OTMs on the eye globe (Fig.1b), the 
distance d between the antenna and the OTM was varied (d=15-30 mm, 
increment=2.5 mm). The spherical shape of the globe was taken into account by 
introducing rotations ranging from 0° to 90° (increment=15°) with the rotation axis 
parallel (γǁ) and perpendicular (γ⊥) to the electric field lines at a representative 
distance of 25 mm.  
For SAR assessments, it is common to use the local SAR (SAR10g) averaged 
over 10 g of tissue (26). This tissue volume largely exceeds the size of an OTM and 
bears the risk of heavy underestimation of local peak SAR (31, 33, 34). To address 
this issue, a smaller averaging volume is required. Consequently, SAR10g was not 
included in the SAR evaluation. Point SAR quantifies the power deposited in a 
volume as small as the simulated resolution. While this provides high spatial 
accuracy, it is highly susceptible to changes in simulated mesh size. Not only does 
the peak SAR changes significantly with rather small changes in mesh size, this also 
constitutes a challenge for the comparability of the acquired data. For these 
reasons, we employed discrete SAR averaging masses ranging from mave=1 g to 
mave=0.01 g.  
The temperature distribution near the OTM was evaluated in thermal 
simulations employing Pennes’ Bioheat equation, an FDTD solver (Sim4Life V2.0, 
ZMT, Zurich, Switzerland) and the virtual phantom in conjunction with the virtual RF 
antenna setup used for the EMF simulations. Thermal simulations were performed 
for one disk position at a distance of d=25 mm from the bow tie antenna, and 
parallel (γǁ=γ⊥=0°) to its main axis. This position was chosen based on strong 
expected interaction (γǁ=γ⊥=0°) while being less prone to overlapping with the 
surface heating of a bow tie antenna (31). The thermal conductivity and heat 
capacity of the tissue simulating material (TSM) were k=0.53 W/(m·K) and 
c=3546 J/(kg·K) to mimic the thermal properties of the sclera (29). An input power 
of Pin=1 W was applied at the bow tie antenna for a duration of t1=6 min and 
t2=15 min. 
Further simulations were conducted by scaling Pin according to the normal 
operating mode governed by the IEC guidelines at the position of SARmax for 
SAR0.01g=10 W/kg and SAR1g=10 W/kg. Only locations with sufficient distance to the 
surface were included in the evaluation, ensuring SAR averaging in the 
homogeneous TSM only. In the same way, the 1st level controlled mode 
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(SARave=20 W/kg) was simulated, scaled to SAR0.01g as well as SAR1g. Based on 
these data, an extra simulation was scaled to reach a maximum temperature 
increase of ΔTmax=1 K. 
Imaging artifacts in phantoms 
To investigate susceptibility-induced artifacts at implant/tissue interfaces, a 
head shaped phantom was constructed. Two spherical holders were incorporated at 
the position of the eyes to accommodate an agarose sample (2% Agarose 
(SeaPaque GTG Agarose, Lonza, Rockland, ME, USA); Fig.1d) containing one OTM. 
Phantom experiments were performed on a 7.0 T whole-body MR system 
(Magnetom, Siemens Healthcare, Erlangen, Germany). A dedicated six-element 
transceiver array was employed for signal transmission/reception (TX/RX) (35). 
Simulated maximum SAR1g in the human voxel model was found to be 
SAR1g(Duke)=4.1 W/kg and SAR1g(Ella)=3.7 W/kg for Pin=1W, not taking into 
account the losses in the interfaces upstream of the TX/RX array. Artifact size and 
shape were investigated using two imaging protocols:  
 T1-weighted gradient echo (GRE):FOV=70 mm, matrix size=256x256, in-plane 
spatial resolution=0.3 mm, slice thickness=1.0 mm, 32 slices, BW=300 Hz/Px, 
nominal flip angle=4°, TR=30 ms, TE=3.9 ms. 
 T2-weighted RARE: FOV=70 mm, matrix size=256x256, in-plane spatial 
resolution=0.3 mm, slice thickness=1.0 mm, 32 slices, BW=300 Hz/Px, 
nominal refocusing flip angle=120°, TR=3000 ms, TE=55 ms, echo train 
length=12.  
For each protocol two acquisitions were performed: one with the OTM positioned 
parallel to B0, and one perpendicular to B0 as suggested by the ASTM standard on 
the evaluation of MR image artifacts of passive implants (36). 
Imaging artifacts in ex vivo porcine eyes 
To establish conditions closer to the clinical scenario, susceptibility artifacts in 
ex vivo pigs’ eyes were evaluated. Three OTMs were sutured to the sclera in 
positions resembling those of markers in PRT (12-14). The eye was then placed in 
the lower half shell of the spherical holder incorporated into the head-shaped 
phantom. After placing the upper half shell, the eye was bathed with a phosphate 
buffer saline (PBS) solution (Biochrom AG, Berlin, Germany) to eliminate 
susceptibility artifacts caused by air bubbles and hydration. Imaging was first 
performed at 7.0 T using the MR hardware and imaging protocols outlined above. 
For additional MR microscopy using a 9.4 T small-bore MR scanner (Biospec 94/20 
USR, Bruker Biospin, Ettlingen, Germany) the eye was moved to a PBS filled stand-
alone spherical holder to fit into the magnet bore. Two sets of GRE and RARE 
imaging were conducted using a 35 mm quadrature volume resonator for TX/RX:  
 MR microscopy protocol: FOV=35 mm, matrix size=512x512, in-plane spatial 
resolution=68 µm, BW=300 Hz/Px; GRE: TR=30 ms, TE=4.4 ms, nominal flip 
angle =10°, slice thickness=350 µm, RARE: TR=11931 ms, TE=47 ms, 
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nominal refocusing flip angle=180°, slice thickness=333 µm, inter-echo 
spacing=11.8 ms, echo train length=12. 
 Low resolution protocol: FOV=70 mm, matrix size=256x256, in-plane spatial 
resolution=0.3 mm, slice thickness=1.0 mm, 32 slices, BW=300 Hz/Px; GRE: 
TR=30 ms, TE=4.4 ms, nominal flip angle=10°; RARE: TR=3931 ms, 
TE=52 ms, nominal refocusing flip angle=180°, inter-echo spacing=8.7 ms, 
echo train length=12. 
Imaging artifacts in ex vivo human eyes with ocular tumor 
After enucleation of a bulbus equipped with OTMs obtained from a patient 
with a therapeutically non-responsive intraocular tumor, an assessment of 
susceptibility artifacts was performed at 7.0 T and additionally at 9.4 T. At 7.0 T the 
globe was placed in the head phantom described above. The holders were filled with 
an isotonic 0.9% NaCl solution (B. Braun Melsungen AG, Melsungen, Germany). MR 
hardware/protocols were identical to the phantom study. In addition, diffusion 
weighted MRI using a RARE variant (22) was performed: FOV=70 mm, matrix 
size=192x192, in-plane spatial resolution=0.4 mm, slice thickness=3.0 mm, 1 slice, 
BW=350 Hz/Px, TR=3300 ms, TE=78 ms, nominal refocusing flip angle=180°, b-
values=0, 100, 200, 300, 400 s/mm².  
For complementary MR microscopy at 9.4 T the globe was placed in a 
spherical holder filled with NaCl solution. Three series of imaging were performed: 
 GRE: FOV=30 mm, matrix size=512x512, in-plane resolution=59 µm, slice 
thickness=300 µm, TR=230 ms, TE=10 ms, nominal flip angle=29°, 
BW=116 Hz/Px.  
 RARE: FOV=30 mm, matrix size=256x256, in-plane resolution=117 µm, slice 
thickness=600 µm, TR=2300 ms, TE=27.5 ms, inter-echo spacing=11.8 ms, 
nominal refocusing flip angle=90°, BW=195 Hz/Px.  
 DWI-RARE: b=0, 200, 500 s/mm², FOV=30 mm, matrix size=256x256, in-
plane resolution=117 µm, slice thickness=600 µm, TR=2300 ms, TE=27.5 ms, 
inter echo spacing=11.8 ms, nominal refocusing flip angle=90°, 
BW=195 Hz/Px.   
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Results 
Magnetically induced displacement 
Magnetic deflection angle measurement showed no measurable deflection 
from the vertical axis, staying well below the 45° reference point (28). With this 
finding any risk imposed by magnetically-induced deflection force to an OTM is 
much smaller than any risk evoked by the gravitational field. 
RF power deposition: Real implant vs. disk approximation 
EMF simulations of an OTM yielded a non-uniform surface current distribution 
with a high current density located in the narrow passages bordering the holes as 
shown for the example of ϑ2=45° (Fig.1e), which presented the highest maximum 
surface currents. Approximating the implant with a disk induces lower surface 
currents with differences of up to -25% (Fig.1f). If the maximum SAR observed for 
the OTM is benchmarked against the maximum SAR obtained for a disk with the 
same geometry except for the holes, we found no discrepancy for any investigated 
orientation ϑi for SAR1g as well as for SAR0.01g (Fig.1g). With this finding, we 
conclude that the disk provides a reasonable approximation of an OTM. This 
approximation has thus been applied for all further simulations. 
SAR averaging mass considerations 
EMF and temperature simulations were performed for our SAR averaging 
mass considerations. Fig.2 illustrates point SAR (per mesh cell) and SAR1g with and 
without the implant analog being present in the phantom. Averaging over 1g 
masses levels out the SAR increase caused by the implant analog, as it can be 
appreciated when comparing SAR1g,disk (Fig.2a) with point SARdisk (Fig.2b). The 
induced SAR increase after averaging over mave=1 g is not only spatially 
indistinguishable but also smeared to the level of the baseline SAR in the TSM 
(Fig.2c,d). With this finding, an accurate evaluation of the local SAR caused by an 
OTM requires mave<1 g.  
The SAR averaging mass should predict an RF power distribution reflecting 
the spatial extent of the potential additional heating caused by the implant (Fig.2e). 
To permit this comparison in RF power/heat distribution, one specific time point of 
the heating paradigm has to be selected. For long RF heating periods of small 
implants, the implant induced temperature increase is surpassed by the baseline 
heating generated by the RF antenna (31). This transition manifests itself in a 
temporal heating curve exhibiting a linear temperature increase showing the same 
slope ΔT/dt with and without the device under investigation (Fig.2f). In our case of 
continuous heating (Pin=1 W), the transition time was found to be 4 s after the 
onset of the heating paradigm. The thermal distribution was thus evaluated after a 
period of 4 s of continuous heating (Fig.2e). 
The spatial extent of SAR and temperature hot spots can be considered as a 
point spread function (PSF; Fig.3a,b). In our case, each hot spot (i.e. each peak on 
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a profile drawn through the SAR hot spot) presents a PSF that needs to be 
sufficiently resolved after applying the mass averaging that acts as a broadening 
filter. Averaging over a mass of 1 g widens the PSF to the extent where the peaks 
at the tip of the implant analog are no longer recognizable (Fig.3c). At the same 
time, the overlap of the broadened peaks introduces increased SAR1g near the 
center of the implant. This contradicts the point SAR distribution, where the bending 
of the electric field lines causes a shielding effect of this region with point SAR 
dropping almost to 0 W/kg (Fig.3a), resulting in a low temperature increase 
(Fig.3b).  
A qualitative and quantitative examination of point SAR (Fig.3a), temperature 
(Fig.3b) and SARave (Fig.3c) distributions was carried out along profiles running 
parallel to the long axis of the RF antenna and through the center of the short axis 
of the phantom (Fig.3a). To assess SAR and temperature increase due to the 
implant analog, the baseline obtained for TSM was subtracted as an offset. The 
resulting profiles represent the increase in SAR (ΔSAR) and temperature (ΔT) 
induced by the implant analog. ΔSAR profiles were evaluated at two different 
distances to the antenna. Profile I goes through the center of a slice placed at a 
depth of d=23.95 mm (Fig.3a), being slightly above the implant in order to 
investigate the overlapping of the two PSFs. Profile II (d=24.95 mm) covers the 
location of the SARmax and the implant analog. To quantify the spatial extent of the 
hotspot obtained from the temperature as well as SAR simulations, the full width at 
half maximum (FWHM) was calculated for the left peak of profile II in the 
distribution of point SAR (ΔSAR, Fig.3a), temperature (ΔT, Fig.3b) and SARave 
(ΔSAR, Fig.3c and Fig.4). 
As a starting point for applying different SAR averaging masses, we 
approached the problem considering the sampling theorem. The distance between 
the two hot spots (i.e. the diameter of the OTM) is 2.5 mm. In order to depict the 
details accurately, the Nyquist theorem requires sampling with a resolution of 
1.25 mm (37). With the TSM density of ρ=1.04 g/cm³, this results in an averaging 
mass of only mave=0.002 g. Not only is this mass a factor of 500 smaller than the 
smallest commonly used averaging mass of SAR1g, it can be also debated as to what 
extent the computational downscaling of investigated spatial distributions is still 
applicable to the complex (thermoregulatory) system of the human body. 
Addressing this limitation, we sought to find the largest averaging volume that 
would accurately depict the PSF of the ΔT profile. The acceptable discrepancy 
between FWHM(ΔT) and FWHM(ΔSAR) was set at 15%. An additional consideration 
of profile I showed the expected increase of SARave above the center of the implant 
analog for all averaging masses. For averaging masses mave>0.015 g, a third 
hotspot appeared above the center of the implant analog (Fig.4a,b). This is caused 
by the overlap of the two PSFs, which underlines the need for a smaller averaging 
volume. In combination with the evaluation of profile II, this returned a SAR 
averaging mass of mave=0.01 g (Fig.4d), resulting in a cube length of a2=2.1 mm in 
the TSM. SAR0.01g was thus used for further evaluation.  
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SAR transfer function 
Next, we studied SAR as a function of the position and orientation of the 
implant analog with respect to the electric field lines. EMF simulations of the disk 
revealed SAR0.01g peak values that follow an exponential decay with increasing 
distance between the antenna and the implant (R²=1; Fig.5a). Observing the same 
behavior in a uniform TSM phantom (“baseline SAR”, Fig.5b), a linear correlation 
was found between SAR0.01g(w) induced by the disk and SAR0.01g(w/o) without the disk, 
with SAR0.01g(w)=1.54·SAR0.01g(w/o), R²=1 (Fig.5c). While SAR1g showed the same 
behavior as SAR0.01g, fitting the data of the disk against baseline SAR1g revealed a 
correlation of only SAR1g(w)=1.005·SAR1g(w/o) (R²=1), quantitatively confirming the 
smearing due to the large averaging volume.  
When the implant analog was rotated around an axis perpendicular to the E-
field lines, thus changing the effective conductive length, a cosine dependence of 
peak SAR0.01g on the rotation angle γ⊥ was found (Fig.5d). For further analysis, the 
data was normalized to the maximum and fitted to a cosine function (R²=0.96; 
Fig.5e). Again, this effect was not visible in the SAR1g data, yielding constant values 
for all orientations. Rotation along the E-field lines γǁ did not alter the effective 
conductive length and did not show an angular dependence of peak SAR0.01g (Fig.5f) 
or SAR1g. 
By fitting local peak SAR0.01g, a transfer function was derived. This transfer 
function enables an a priori estimation of induced SAR0.01g(w) in the presence of the 
implant based on its rotation perpendicular to the electric field lines and baseline 
SAR0.01g(w/o) caused by the RF antenna without the presence of the implant (Fig.5g). 
SAR0.01g(w)(γ)=1.54 · (0.1·cos(2γ⊥)+0.87) · SAR0.01g(w/o)+0.3 W/kg       (1) 
The constant offset of 0.3 W/kg was added as a safety margin to compensate for 
underestimation of the simulated data introduced by the fitting process.  
Maximum SAR0.01g of 2.64 W/kg in the presence of the implant analog was 
found for d=15 mm and γ⊥=0°. SAR0.01g at the surface of the phantom centered 
underneath the antenna was SAR0.01g(surface)=2.68 W/kg. For mave=1 g, a maximum 
power deposition was found at the phantom surface SAR1g(surface)=2.26 W/kg while 
maximum SAR1g(disk)=1.74 W/kg was exhibited at a distance of d=15 mm. 
RF induced heating 
In all cases, the maximum SAR was found at the phantom surface. Only 
locations with sufficient distance to the surface were included in the evaluation, 
ensuring SAR averaging in the homogeneous TSM only. For mave=0.01g (averaging 
cube length a0.01g=2.11 mm) highest SAR0.01g was found at d=1.15mm within the 
TSM, centered underneath the RF antenna. This is consistent with the averaging 
volume constituted of homogeneous TSM at the shortest distance to the power 
source. The larger averaging volume of mave=1g with a1g=9.8 mm exhibited highest 
SAR1g at d=4.65mm. The temperature increase denoted as ΔTsurface was extracted at 
the position of the maximum SARave used for Pin normalization. The temperature 
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increase at the implant analog ΔTdisk was evaluated at the position of maximum 
SAR0.01g. The same location was used for the reference ΔTTSM. 
Thermal simulations provided a super-linear implant related temperature 
increase right after the onset of RF power (Fig.6a). After 4 s of heating a linear 
temperature increase was found. The slope Tdisk/dt was identical with the TTSM/dt 
obtained for the same phantom location and setup but without the implant analog. 
This indicates that the thermal flux along the temperature gradient of the hot spot 
at the implant reached equilibrium with the surrounding tissue. It also suggests that 
a purely SAR-based estimation of temperature increase is likely to overestimate 
induced heating near an implant (blue line in Fig.6a). After only 2 s of heating, the 
temperature at the implant analog was surpassed by the temperature at the 
phantom surface (ΔTsurface(2s)=1.3 mK, ΔTdisk(2s)=1.2 mK). This indicates a 
transition from an implant-dominated heating regime (t<2 s) to a surface-
dominated heating regime (t>2 s). The relation was maintained until the end of the 
heating paradigm. The simulation (Pin=1 W, duration tRF=6 min) yielded a total 
temperature increase of ΔTsurface=185 mK at the phantom surface and 
ΔTdisk=103.1 mK at the disk. When compared with the heating curves obtained for 
the TSM without the implant analog, the presence of the disk in the phantom caused 
an additional maximum heating of δTdisk-TSM=1.4 mK. The same behavior  
When scaling Pin to the normal operating mode (NM) and 1
st level controlled 
mode (CM), peak SAR0.01g=10 W/kg caused a temperature increase of 
ΔTmax=641.3 mK at the surface and ΔTdisk=381.7 mK at a baseline SAR of 
SAR0.01g(W/O)=3.66W/kg (Fig.6b, Table 1). Additional heating with respect to the TSM 
was δTmax=5.2 mK. The CM (SARave=20 W/kg) resulted in ΔTmax=1283.1 mK at the 
surface and ΔTdisk=763.4mK. Additional heating with respect to the TSM was 
δTmax=10.4 mK. Scaling Pin to obtain ΔTmax=1 K limited the input power such that 
max SAR1g,max=12.3 W/kg and SAR0.01g,max=15.5 W/kg. In all cases, the highest 
temperature increase occurred at the phantom surface.  
When extending the simulation time to 15 min to cover typical clinical scan 
times (38-40), surface temperature exceeded ΔTmax=1 K for the normal as well as 
the 1st level controlled mode. This temperature increase was reached with 
max(SAR0.01g(W/O))=3.02 W/kg and max(SAR1g(W/O))=2.81 W/kg. In all cases, 
maximum temperature increase was found at the phantom surface. 
With increasing input power, the temperature difference between the disk 
and TSM as well as the temperature margin between disk and surface increases 
(Table 1). However, the transition time from a SARdisk-dominated to SARbaseline-
dominated regime was found to be ttrans=4 s in all cases. Increasing the heating 
time from 6 min to 15 min showed a constant offset δTsurface-disk (±2·10
-4 K) for all 
levels of input power. This supports the theory of an underlying equilibrium with the 
magnitude of the offset depending on the input power. 
Imaging artifacts in phantoms 
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Fig.7 summarizes the susceptibility artifacts acquired for the uniform agarose 
phantom using the GRE and RARE protocols. Size and shape differ with changing 
orientation of the OTM and the imaging plane with respect to B0. Alignment of the 
long axis of the implant with B0 increases the susceptibility artifact in this direction. 
Maximum artifact size was (8.4x7.5) mm² for the GRE and (8.0x7.8) mm² for the 
RARE protocol. 
Imaging artifacts in ex vivo porcine eyes 
Fig.8 surveys susceptibility artifacts obtained from ex vivo pigs’ eyes at 7.0 T 
and 9.4 T. The GRE protocol showed significant susceptibility artifacts induced by 
the OTM. The RARE protocol was less prone to susceptibility artifacts related to the 
OTM. At 7.0 T, maximum artifact size was (4.6x7.2) mm² for the GRE and 
(3.2x4.2) mm² for the RARE protocol for which the extension of the susceptibility 
artifact towards the vitreous humour barely exceeds the thickness of the sclera.  
No major differences in artifact geometry and size were found at 7.0 T and 
9.4 T. Maximum artifact size acquired with low resolution at 9.4 T was 
(4.1x6.9) mm² for the GRE and (3.3x 4.8) mm² for the RARE protocol. The high 
resolution GRE protocol helped to reduce the artifact size to (2.6x6.3) mm² due to a 
smaller voxel size and a higher bandwidth per anatomy.  
Imaging artifacts in ex vivo human eyes with ocular tumor 
Fig.9 surveys the 7.0 T (Fig.9a-c) and 9.4 T (Fig.9d-f) MRI results for an 
enucleated human eye. GRE and RARE imaging clearly display the ocular mass, 
severe retinal detachment and the retained fraction of the vitreous humour. The 
7.0 T data include a susceptibility artifact caused by the OTM marked by an arrow 
(Fig.9a-c). Maximum artifact size was (6.0x7.4) mm² for the GRE and 
(5.5x6.5) mm² for the RARE protocol. 
ADC maps obtained at 7.0 T and 9.4 T show a clear delineation of subretinal 
space, the tumor and the vitreous humour. ADC’s obtained at 7.0 T accord with 
those derived from DWI at 9.4 T: ADCsubretinal space,7T=(1.75±0.11)·10
-3 mm²/s vs. 
ADCsubretinal space,9.4T=(1.84±0.05)·10
-3 mm²/s, ADCtumor,7T=(0.58±0.29)·10
-3 mm²/s 
vs. ADCtumor,9.4T=(0.57±0.13)·10
-3 mm²/s, ADCvitreous humour,7T=(0.22±0.06)·10
-
3 mm²/s vs. ADCvitreous humour,9.4T=(0.22±0.05)·10
-3 mm²/s).  
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Discussion 
This is the first study that examined the potential MR safety hazards and MR 
compatibility issues of ocular tantalum markers for ophthalmic MRI at 7.0 T.  
From the methodological point of view, our numerical simulations show that 
an OTM can be conveniently approximated by a disk. Our SAR averaging mass 
considerations demonstrated a strong need to use averaging masses that are three 
orders of magnitude smaller than mave=10g provided by IEC guidelines to 
accommodate the small size of an OTM for an accurate SAR assessment.  
The EMF simulations helped to derive a transfer function which describes local 
SAR0.01g induced by an OTM interfering with E-fields generated by an arbitrary RF 
coil configuration. This generalization allows SAR assessment without the need for 
EMF simulations with the OTM being integrated. The proposed transfer function can 
be incorporated into state-of-the art SAR prediction concepts (41, 42) to provide 
SAR estimations induced by OTMs for arbitrary RF pulses used for transmission field 
shimming (43, 44) or parallel transmission (45, 46).  
The performed deflection angle measurements demonstrated that any risk 
imposed by magnetically-induced deflection force to an OTM is much smaller than 
any risk evoked by the gravitational field. Considering that an OTM is sutured to the 
sclera in an in vivo situation, it is highly unlikely that interference with the magnetic 
field will induce any displacement of an OTM. This finding correlates well with prior 
assessment of the negligible ferromagnetism of tantalum implants (47, 48). This 
conclusion applies to 7.0 Tesla MR as well as to 1.5 T and 3.0 T MR, since the 
strongest magnetic B0 gradient is similar for these instruments. This finding adds to 
the literature since to the best of our knowledge, no data on the MR safety of OTMs 
has been presented for the current clinically relevant static magnetic field strengths. 
RF heating induced by an OTM is another safety concern addressed in this 
work. At 7.0 T the RF wavelength  in orbital muscle, brain tissue and vitreous 
humour interfacing the sclera is approximately 12-13 cm. This wavelength range 
exceeds an OTM diameter of 2.5 mm used in clinical practice, so that it is highly 
unlikely that resonance effects occur at /4 - /2 for OTMs (49). This conclusion 
applies equally to clinical MR scanners, where the wavelength in orbital muscle, 
brain tissue and vitreous humour at the interface to sclera is approximately 26-
30 cm (3.0 T) or 43-57 cm (1.5 T).  
EMF simulations provided a maximum SAR0.01g of 2.64 W/kg (Pin=1W) in the 
presence of an OTM analog. In comparison, a maximum SAR0.01g=2.68 W/kg was 
found for phantom regions closest to the RF antenna, indicating that the OTM did 
not generate the highest SAR for the target region. An input power of Pin,NM=3.73 W 
or Pin,CM=7.46 W would be feasible while staying within the safety limits established 
by IEC guidelines. For averaging masses of mave=1 g, SAR1g a power of 
Pin,NM=4.43 W or Pin,CM=8.85 W can be used without exceeding the limits in the IEC 
guidelines (26). 
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The thermal simulations provided valuable insights into how local SAR at the 
OTM translates into tissue temperature increase and suggested a transition from an 
implant dominated heating regime (t<2 s) to a surface heating dominated mode 
(t>2 s). After 4 s of heating a linear temperature increase was found. The slope 
T/dt observed in the presence of the OTM analog was identical with T/dt obtained 
for the same location and configuration except the OTM, meaning that the 
properties of the OTM and surrounding tissue act as a heat sink removing 
temperature from the OTM. Increased input powers scaled to the maximum SARave 
values for the normal operating mode and the 1st level controlled mode as well as 
maximum temperature rise of 1 K reveal equal transition times of 4 s. When 
extending the simulation time to 15 min, the offset caused by the implant is 
constant for all power levels. Taken together, this supports our hypothesis that the 
temporal occurrence of the equilibrium is linked to the distance between the two 
hotspots. At the same time, the temperature margin at the end of the heating 
paradigm between surface, disk analog and TSM increases with increasing input 
power. Following guidelines limiting the maximum acceptable temperature increase 
to ΔTmax=1 K, the input power was limited such that SAR1g,max=3.11 W/kg for the 
more restrictive SARave and the longer heating period of tRF=15 min. Obviously, the 
increase in temperature obtained for the phantom situation is likely to overestimate 
the actual temperature rise in vivo. The thermal properties and the 
thermoregulation (i.e. perfusion) of the tissue that is affected will reduce the 
temperature increase near the OTM. 
It is a recognized limitation of this study that no temperature measurements 
are included. It has been shown that even for larger implants (i.e. larger hotspots), 
that changes in temperature sensor positioning of less than 0.5 mm result in 
erroneous temperature measurements induced by infidelities in the probe placement 
(50). Considering this finding together with the subtle spatial extent of the 
temperature hotspot caused by the OTM, no temperature measurements were 
executed. For similar reasons, this study does not include random positions for 
temperature assessment as suggested for heating experiments (REF). Due to the 
overall small increase in temperature caused by the implant when compared to 
baseline heating, we limited our investigation to the implant position that hinted at 
the strongest discernable temperature increase. 
Finally, the presented work investigated image artifact formation induced by 
OTMs in order to make a statement on MR compatibility at 7.0 T. If an OTM induces 
a major susceptibility artifact, this might lead to diagnostic misinterpretations 
and/or it may mistakenly be attributed to pathology, if it not recognized as an 
artifact. It is known that subtle metallic implants used in ophthalmology, such as 
platinum-carrying intraocular lenses and platinum-containing eyelid implants can 
cause low-level susceptibility artifacts (51, 52). Our T1-weighted and T2-weighted 
phantom imaging studies revealed susceptibility artifacts with a size smaller than 
8.5 mm. The artifact size obtained for ex vivo imaging of porcine eyes as well as ex 
vivo imaging of human eye was smaller (<7.5 mm). T2-weighted RARE imaging in 
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ex vivo porcine eyes demonstrated that the extension of the susceptibility artifact 
towards the vitreous humour barely exceeded the sclera.  
The findings of small susceptibility artifacts is in good agreement with prior 
work, identifying tantalum as a low susceptibility material (χ=0.97·10-6 (53)), 
causing only small imaging artifacts (54, 55). GRE and RARE imaging of ex vivo 
human eyes with ocular tumors showed a clear delineation of subretinal space and 
vitreous humour. RARE-based ADC mapping of ex vivo humans eyes at 7.0 T 
exhibited a clear discrimination of the tumor mass. These are potential criteria that 
support an admission of patients with OTMs for MRI at 7.0 T.  
One possible indication for 7.0 T imaging is the question whether the tumor 
has already infiltrated the optic nerve (56). Despite the slightly bigger artifacts of 
the OTM (5.3 mm for 7.0 T MRI vs. 4.7 mm for 3.0 T MRI) 7.0 T MRI will be of 
benefit for the treatment planning of ophthalmologic proton therapy: The contours 
of big tumors should be more realistic. The enhanced spatial resolution would afford 
an improved differentiation between tumor and retinal detachment. Small extra 
scleral tumor growth along or in the optic nerve can be detected and modelled in 
the treatment planning procedure. This allows to irradiate patients with small optic 
nerve infiltration (up to 3 mm length) with protons and to preserve their eye. The 
blind spots caused by the artifacts of the OTM placed near the tumor may interfere 
with its delineation in treatment planning. This can be compensated with other 
information from fundus photography, ultrasound imaging, and measurements 
obtained during OTM surgery. Artifacts near the optic nerve are not expected 
because the distance of the OTM placed near the tumor and the optic nerve is 
usually greater than 7 mm.  
The OTMs investigated in this study were obtained by the only manufacturer 
providing CE certification for the use of the markers in proton beam therapy of 
ocular tumors. In conclusion, all ocular tantalum markers commercially available 
today with CE certification for PRT can be considered safe for MR at field strengths 
of up to and including 7.0 Tesla.  
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Tables 
6 min 
SAR limits  NM 
(SAR0.01g) 
NM (SAR1g) CM 
(SAR0.01g) 
CM (SAR1g) ΔTmax=1K  
at max(SAR0.01g) 
ΔTmax=1K  
at max(SAR1g) 
Pin [W] 1 3.7 4.44 7.4 8.89 5.77 5.44 
ΔTsurface,0.01g [mK] 173.0 641.3  1283.1  1000.5  
ΔTsurface,1g [mK] 185.0  814.3  1630.4  997.5 
ΔTdisk [mK] 103.1 381.7 458.0 763.4 917.1 595.2 561.2 
δTsurface-disk [mK] 69.9/81.9 259.6 356.3 519.7 713.3 405.3 436.3 
ΔTTSM [mK] 101.7 376.5 451.8 753.0 904.7 587.2 553.6 
δTdisk-TSM [mK] 1.4 5.2 6.2 10.4 12.4 8 7.6 
15 min 
SAR limits  NM 
(SAR0.01g) 
NM (SAR1g) CM 
(SAR0.01g) 
CM (SAR1g) ΔTmax=1K at 
max(SAR0.01g) 
ΔTmax=1K at 
max(SAR1g) 
Pin [W] 1 3.7 4.44 7.4 8.89 3.05 2.84 
ΔTsurface,0.01g [mK] 268.3 1233.9  2557.4  1001.4  
ΔTsurface,1g [mK] 301.8  1614  3302.8  1001.7 
ΔTdisk [mK] 231.2 911.1 1100 1842.8 2218.0 747.4 694.6 
δTsurface-disk [mK] 37.1/70.6 322.8 514 414.6 1084.8 254 307.1 
ΔTTSM [mK] 229.8 905.9 1093.7 1832.3 2205.4 743.1 690.5 
δTdisk-TSM [mK] 1.4 5.2 6.3 10.5 12.6 4.3 4.1 
 
Table 1: Temperature increase obtained for 6 min of continuous RF heating with different input power. ΔT marks the 
temperature increase at the location “disk”, i.e. point of highest SAR0.01g near the implant analog, “TSM”, i.e. at the 
same location but without the implant being present and “surface”, i.e. point of highest SARave averaged in the 
continuous virtual phantom. δT denotes the temperature difference between two of these locations (disk vs. TSM and 
surface vs. disk) after the RF heating.  
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Figures 
 
Figure 1: (a) Schematic view of an ocular tantalum marker (OTM) outlining its 
dimensions. (b) Exemplary location of the tantalum markers (yellow) on an eye 
(back view) with highlighted intraocular tumor mass (red), optic nerve (brown) and 
macula (blue). (c) Virtual simulation setup with a bow tie dipole RF antenna building 
block placed on top of a rectangular PMMA box filled with tissue simulating material 
(TSM). Two high resolution meshboxes limit the resolution to 0.1 mm isotropic (red) 
and 0.05 mm isotropic (blue) around the implant. (d=25 mm, γǁ=γ⊥=0°). (d) 
Agarose phantom sample with incorporated OTM placed in the lower half shell of the 
spherical holder. (e) Absolute value of induced surface current (Pin=1 W, ϑ2=45°, 
d=25 mm, γǁ=γ⊥=0°). Maximum surface current of 2.17 A/m is found in the 
narrowed passage next to the right hole. (f) Absolute value of induced surface 
current for Pin=1 W for the disk at the same position. The maximum surface current 
is 1.64 A/m and up to 25% lower than for the OTM. (g) Induced RF power 
deposition for implant orientation ϑi and for a disk with the same outer dimensions 
(grey box). For SAR averaging masses of mave=1 g and mave=0.01 g, no difference 
can be seen for the different surface currents. 
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Figure 2: (a,b) Sagittal view of the local SAR distributions obtained for a virtual 
ocular tantalum marker analog positioned underneath the virtual RF antenna 
(d=25 mm, γǁ=γ⊥=0°). Averaging the induced SAR over masses of 1 g (a) levels out 
peak values depicted in the meshcell-wise calculation (“point SAR”, b) to a point 
that corresponds to the SAR values found in the homogeneous tissue simulating 
material (TSM; c,d). (e) Temperature distribution after a heating period of 4 sec. (f) 
Temperature curves recorded at the point of highest point SAR (green cross in 
b,d,e) at the rim of the implant analog (red), at the respective position in the 
homogeneous TSM (yellow) and at in the surface region of the TSM at the point of 
highest temperature increase (black). The temperature increase caused by the 
implant analog goes into saturation after 4 s (blue dashed line). Further 
temperature increase is caused by the baseline RF power deposition, as indicated by 
the same slope ΔT/dt (green dashed line) when compared to the homogeneous 
TSM. All simulations: Pin=1 W. 
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Figure 3: (a) Sagittal view of SAR per mesh cell (0.05 mm isotropic) for a virtual 
ocular tantalum marker analog (d=25 mm, γǁ=γ⊥=0° Pin=1 W). Profile I is drawn at 
a depth of d=23.95 mm, slightly above the implant analog. Profile II represents a 
line through the SAR maximum near the disk implant at a depth of d=24.95 mm. 
Both profiles show the increase due to the presence of the implant analog (ΔSAR) 
after subtraction of the baseline SAR. (b) Temperature distribution and ΔT profiles 
after a heating period of 4 s. (c) SAR1g distribution. The blue square indicates the 
face of the averaging cube with a side length of a1g=9.8 mm in the TSM. The ΔSAR 
profiles represent the SAR increase due to the implant analog. 
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Figure 4: Sagittal view of the SAR distribution for averaging volumes of (a) 0.05 g, 
(b) 0.025 g, (c) 0.015 g and (d) 0.01 g. The blue squares indicate the faces of the 
averaging cubes with side lengths of a0.05g=3.6 mm, a0.025g=2.9 mm, 
a0.015g=2.43 mm and a0.01g=2.1 mm in the TSM. SAR0.01g yields no third hot spot in 
profile I and a broadening of FWHM of less than 15 % in profile II compared to the 
temperature profile. 
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Figure 5: Peak SAR values for SAR0.01g and SAR1g. (a) Induced SAR near the implant 
analog shows an exponential decay (R²=1) with increasing distance of the disk to 
the RF antenna. (b) The same behavior can be seen in the uniform TSM (R²=1) 
suggesting (c) a linear correlation (R²=1) between peak SAR without implant and 
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peak SAR with implant. While SAR0.01g is increased by a factor of 1.54 vs. baseline, 
smearing due to the large averaging volume of mave=1g yields an increase of only 
1.005. (d) Rotation γ⊥ of the disk out of the electric field lines leads to a cosine 
decay of the SAR0.01g values. (e) The normalized SAR values are fitted to the 
expected cos(2γ⊥) dependence (R²=0.96). (f) Rotation γǁ of the disk in the electric 
field lines shows no angular dependence. (g) SAR0.01g (w) induced by the implant 
analog estimated using the transfer function (equation 1). 
 
Figure 6: (a) RF heating curves obtained for continuous heating with an input power 
of Pin=1W. The temperature recorded at the point of highest SAR in the vicinity of 
the implant analog (red) goes into saturation after 4 s (dashed blue line). The 
subsequent temperature increase follows the same slope ΔT/dt (dashed green line) 
as observed at the same position in the homogeneous TSM (yellow markers, green 
line). After only 2 s of RF heating and onwards, the temperature in the vicinity of 
the implant is surpassed by the temperature increase in the surface region of the 
phantom (black). Making a SAR based estimation of the temperature increase would 
not foresee the saturation effect and largely overestimate the resulting temperature 
increase (blue line). (b,c) Thermal simulation results after 6 min and 15 min of 
continuous RF heating for Pin=1 W, when scaling the input power to the normal 
mode and the 1st level controlled mode and to a maximum temperature increase of 
ΔT=1 K. Scaling based on SAR0.01g (dot) and SAR1g (square) yield different input 
powers and temperatures. All values are listed in table 1. 
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Figure 7: Magnified view of the phantom images acquired at 7.0 T with the implant 
embedded in a homogeneous agarose sample. The transparent phantom allowed 
alignment of the implant perpendicular and parallel to the main magnetic field. 
Rotation of the implant into the magnetic field lines increases the dimension of the 
susceptibility artifact in the z-direction (sagittal and coronal slices). T1-weighted 
gradient echo (GRE) imaging was applied using FOV=70 mm, matrix size=256x256, 
in-plane spatial resolution=0.3 mm, slice thickness=1 mm, 32 slices, BW=300 
Hz/Px, nominal flip angle=4° TR=30 ms, TE=3.9 ms, acquisition time=9:14 min. T2-
weighted rapid acquisition with relaxation enhancement (RARE) imaging was 
employed with FOV=70 mm, matrix size=256x256, in-plane spatial resolution=0.3 
mm, slice thickness=1 mm, 32 slices, BW=300 Hz/Px, TR=3000 ms, TE=55 ms, 
nominal refocusing flip angle=120°, turbo factor=12, acquisition time=3:20 min. 
The two protocols show significant differences in artifact shape and prominence but 
no significant differences in size. 
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Figure 8: Ex-vivo imaging of a pig eye equipped with three ocular tantalum markers 
at 7.0 T and 9.4 T. Depicted is the slice with the maximum artifact dimension. The 
estimated implant position is shown in red. Artifact size obtained for the 7.0 T and 
9.4 T GRE protocol is similar to that observed for the homogeneous agarose sample. 
For RARE imaging the artifact size is approximately half the size of that found for 
the homogeneous sample.  
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Figure 9: Ex-vivo tumor eye imaging at 7.0 T and 9.4 T. All anatomical images show 
the delineation of the ocular mass, severe retinal detachment as well as the small 
remaining fraction of the vitreous humour. The slice selected at 7.0 T (a,b) 
comprises a susceptibility artifact caused by an ocular tantalum marker (arrow). 
After transferring the eye ball to a smaller holder for imaging at 9.4 T, the slice 
position was not reproduced. The slice depicted at 9.4 T (d,e) shows the root of the 
optic nerve (arrow), separated from the tumor by a slight delineation. Histology 
confirmed that the tumor had not yet infiltrated the optic nerve. Apparent diffusion 
coefficients (ADC) obtained at 7.0 T (c) and 9.4 T (f) are in good agreement (7.0 T 
vs. 9.4 T: subretinal space: ADC7.0T=(1.75±0.11)·10
-3 mm²/s, 
ADC9.4T=(1.84±0.05)·10
-3 mm²/s; tumor: ADC7.0T=(0.58±0.29)·10
-3 mm²/s, 
ADC9.4T=(0.57±0.13)·10
-3 mm²/s; vitreous humour: ADC7.0T=(0.22±0.06)·10
-
3 mm²/s, ADC9.4T=(0.22±0.05)·10
-3 mm²/s).   
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